Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
|
US |
|
LNA Sante SA
PAR:LNA
|
FR |
|
MTR Corp Ltd
F:MRI
|
HK |
|
M
|
Medifast Inc
XBER:MDF
|
US |
|
H
|
Hong Kong and China Gas Co Ltd
XHAM:HCG
|
HK |
|
A
|
Akamai Technologies Inc
DUS:AK3
|
US |
Wall St Price Targets
RIGL Price Targets Summary
Rigel Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for RIGL is 54.26 USD with a low forecast of 38.38 USD and a high forecast of 85.05 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RIGL's stock price target?
Price Target
54.26
USD
According to Wall Street analysts, the average 1-year price target for RIGL is 54.26 USD with a low forecast of 38.38 USD and a high forecast of 85.05 USD.
What is the Revenue forecast for Rigel Pharmaceuticals Inc?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Revenue has been 45%. The projected CAGR for the next 8 years is -2%.
What is the Operating Income forecast for Rigel Pharmaceuticals Inc?
Projected CAGR
-7%
The compound annual growth rate for Operating Income over the next 8 years is -7%.
What is the Net Income forecast for Rigel Pharmaceuticals Inc?
Projected CAGR
-17%
The compound annual growth rate for Net Income over the next 8 years is -17%.
